1 / 16

Are Women with Diabetes Under-treated for Dyslipidemia?

Are Women with Diabetes Under-treated for Dyslipidemia?. Sherrie H. Kaplan, PhD, MPH Professor of Medicine UCI School of Medicine Academy Health 2006 Annual Research Meeting. Background.

hiero
Download Presentation

Are Women with Diabetes Under-treated for Dyslipidemia?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Are Women with Diabetes Under-treated for Dyslipidemia? Sherrie H. Kaplan, PhD, MPH Professor of Medicine UCI School of Medicine Academy Health 2006 Annual Research Meeting

  2. Background • Less than 1/3 of men and 1/5 of women with diabetes have LDL-levels at target (<100mg/dl), Jacobs MJ, et al., Diab Res and Clin Pract 2005, 70:263-269 • Underuse of lipid-lowering therapy among women with cardiovascular disease (HERS, PREVENT, etc.)

  3. Background • Physician gender bias in prescribing of lipid lowering therapies among women with CAD (Abuful A, et al.) • Diabetes greater risk factor for ischemic heart disease for women than for men (Barrett-Connor, et al., JAMA 1991; Larsson, et al., Diabetes Care; Barrett-Connor, et al., Arch Intern Med, etc.)

  4. Background • At same lipid levels, women with cardiovascular disease have lower mortality risk compared to men; women with diabetes have same or greater mortality risk compared to men

  5. Research Questions • Are there gender differences: • in monitoring lipid levels among patients with diabetes? • in lipid control among patients with diabetes? • If so, are there gender differences in overall quality of diabetes care? • Do findings persist across patient samples?

  6. Study Samples • Patients of physicians participating in the ADA Provider Recognition Program (n=7364) • Patients with diabetes at Kaiser Permanente Georgia (n=14,671) • Patients participating in the UCI Diabetes Coached Care Program (n=272)

  7. Patient Characteristics:PRP Sample

  8. Patient Characteristics:Kaiser Sample

  9. Patient Characteristics:UCI Sample

  10. Gender Differences in Lipid Monitoring and Control

  11. Gender differences in overall quality of diabetes care: PRP

  12. Gender differences in overall quality of diabetes care: KPG

  13. Gender differences in overall quality of diabetes care: UCI

  14. Results of multi-variable analyses • In separate logistic regression models predicting LDL <100 and <130, gender significant, adjusted for age, education, health status and on insulin • Odds ratio for treatment with statins if LDL >130 for women = 0.77, p< .001 (KPG data only)

  15. Summary • With no differences in the overall quality of diabetes care, nor in monitoring of lipids, women have poorer lipid control • Results observed in three different patient samples • Women with diabetes and poor lipid control significantly less likely to be on statins

  16. Policy Implications • For patients with diabetes, women may be under-treated for dyslipidemia • Women with diabetes should be targeted for more aggressive treatment to reduce LDL levels and subsequent cardiovascular risk

More Related